.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Colorcon
US Department of Justice
Daiichi Sankyo
Chinese Patent Office
McKesson
Medtronic
Merck
AstraZeneca
US Army

Generated: June 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,299,209

« Back to Dashboard

Claims for Patent: 8,299,209

Title:Pharmaceutical composition comprising cyclic somatostatin analogues
Abstract: Pharmaceutical compositions comprising a somastatin analogue in the form of a liquid formulation for parenteral administration are disclosed.
Inventor(s): Lambert; Olivier (Spechbach-le-Haut, FR), Moser; Katrin (Brookline, MA)
Assignee: Novartis AG (Basel, CH)
Application Number:12/359,527
Patent Claims: 1. A liquid formulation for parenteral administration comprising tartaric acid and a somatostatin of formula II ##STR00008## wherein the configuration at C-2 is (R) or (S) or a mixture thereof, and wherein R is NR.sub.1 R.sub.2--C.sub.2-6 alkylene or guanidine-C.sub.2-6 alkylene, and each of R.sub.1 R.sub.2 independently is H or C.sub.1-4 alkyl, in free form, salt form, or protected form.

2. The liquid formulation according to claim 1 wherein the compound of the somatostatin is in aspartate di-salt form.

3. The liquid formulation according to claim 1 wherein the formulation is adjusted to a pH of about 4 to about 4.5.

4. The liquid formulation according to claim 1 wherein the somatostatin is cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O)Pro}-Phg-DTrp-Lys-Tyr(4-- Bzl)-Phe] or a pharmaceutically acceptable salt thereof.

5. The liquid formulation according to claim 2 wherein the somatostatin is cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O)Pro}-Phg-DTrp-Lys-Tyr(4B- zl)-Phe] or a pharmaceutically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Teva
US Department of Justice
Queensland Health
McKesson
AstraZeneca
Chubb
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot